These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 176392)

  • 21. [New antigens induced by herpes simplex virus in human tumors].
    Posevaia TA; Grigor'ev VV; Kosiakova NP; Barinskiĭ IF
    Vopr Virusol; 1981; (2):193-5. PubMed ID: 6267821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralization, immunofluorescence and complement fixation tests in identification of antibody to a herpesvirus type 2-induced, tumor-specific antigen in sera from squamous cervical carcinoma.
    Aurelian L; Strandberg JD; Marcus RL
    Prog Exp Tumor Res; 1974; 19():165-81. PubMed ID: 4612606
    [No Abstract]   [Full Text] [Related]  

  • 23. Application of indirect hemagglutination test to measurement of type specific antibody to herpes simplex virus in human sera.
    Ohashi M; Ozaki Y
    Microbiol Immunol; 1979; 23(8):801-4. PubMed ID: 232237
    [No Abstract]   [Full Text] [Related]  

  • 24. An evaluation of herpes simplex virus antigenic markers in the study of established and developing cervical neoplasia.
    Smith CC; Aurelian L; Gupta PK; Frost JK; Rosenshein NB; Klacsmann K; Geddes S
    Anal Quant Cytol; 1980 Jun; 2(2):131-43. PubMed ID: 6255843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herpes simplex virus. An expanding relationship to human cancer.
    Smith JW
    J Reprod Med; 1983 Feb; 28(2):116-22. PubMed ID: 6300393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of antibody to a virus-induced tumor-associated antigen (AG-4) in Japanese sera from patients with cervical cancer and controls.
    Kawana T; Cornish JD; Smith MF; Aurelian L
    Cancer Res; 1976 Jun; 36(6):1910-4. PubMed ID: 1268845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunofluorescence study of the presence of herpes type 1 and type 2 antigens in patients with cancer of the uterine cervix.
    Athanasiu P; Nastac E; Stoian M; Predescu E; Hozoc M
    Virologie; 1978; 29(4):251-3. PubMed ID: 219590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme-linked immunosorbent assay for herpes simplex virus tumor-associated antigen.
    Cocchiara R; Tarro G; Flaminio G; Di Gioia M; Geraci D
    Cancer; 1980 Mar; 45(5):938-42. PubMed ID: 6266632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unusual serologic response to two patients to an early antigen of herpes simplex virus type 2.
    Arsenakis M; May JT
    Sex Transm Dis; 1982; 9(3):143-5. PubMed ID: 6293106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutralizing serum IgM antibodies in infections with Herpes simplex virus hominis.
    Doerr HW; Gross G; Schmitz H
    Med Microbiol Immunol; 1976 Dec; 162(3-4):183-92. PubMed ID: 187917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of herpes simplex virus type-2 antigen(s) in biopsies from carcinoma of the uterine cervix.
    Thankamani V; Kumari TV; Vasudevan DM
    J Exp Pathol; 1985; 2(2):123-33. PubMed ID: 2431113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of herpes simplex type 2 virus with cervical cancer of the uterus.
    Kao CL; Chen YH; Tang MC; Wen HK; Hsia S
    Taiwan Yi Xue Hui Za Zhi; 1974 Feb; 73(2):122-7. PubMed ID: 4368434
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies demonstrating the immunological identity of the tumour-associated antigen AG-4 with a virion envelope protein.
    Strnad BC; Smith MF; Aurelian L
    IARC Sci Publ (1971); 1978; (24 Pt 1):203-13. PubMed ID: 87365
    [No Abstract]   [Full Text] [Related]  

  • 34. Detection of herpes simplex virus tumor-associated antigen in uterine cervical cancer tissue: five case studies.
    Notter MF; Docherty JJ; Mortel R; Hollinshead AC
    Gynecol Oncol; 1978 Dec; 6(6):574-81. PubMed ID: 220150
    [No Abstract]   [Full Text] [Related]  

  • 35. Reaction of antigens isolated from herpes simplex virus-transformed cells with sera of squamous cell carcinoma patients.
    Notter MF; Docherty JJ
    Cancer Res; 1976 Dec; 36(12):4394-401. PubMed ID: 187320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An immuno-enzymatic assay for herpes simplex virus tumour associated antigen in gynecological oncology.
    Magli G; Scimone C; Flaminio G; D'Alessandro G; Mascolo A; Magli R; Saladino I
    Eur J Gynaecol Oncol; 1982; 3(2):101-6. PubMed ID: 6299742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgG-, IgA- and IgM-antibodies to herpes simplex virus type 2 in sera from patients with cancer of the uterine cervix.
    El Falaky IH; Vestergaard BF
    Eur J Cancer (1965); 1977 Mar; 13(3):247-51. PubMed ID: 193693
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum antibodies to herpesvirus early antigens in patients with cervical carcinoma determined by anticomplement immunofluorescence technique.
    Ito H; Tsutsui F; Kurihara S; Akabayashi T; Tobe T
    Int J Cancer; 1976 Nov; 18(5):557-63. PubMed ID: 62718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of the nature of herpesvirus-induced tumour-associated antigens induced by herpes simplex virus type 1 and further analysis of their relationship with squamous-cell carcinomas of the head and neck region.
    Hollinshead AC; Chretien PB; Tarpley JL
    IARC Sci Publ (1971); 1975; (11 Pt 2):307-11. PubMed ID: 191376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic relationship between herpes simplex viruses, human cervical cancer and HSV-associated hamster tumours.
    Nahmias AJ; Del Buono I
    IARC Sci Publ (1971); 1975; (11 Pt 1):309-13. PubMed ID: 190133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.